Antioxidant, Enzyme Inhibitory, and Protective Effect of Amelanchier lamarckii Extract

• Published in: Plants (Basel) 2024-05, Vol.13 (10), p.1347
• Main Authors: Dăescu, Adela Maria, Nistor, Mădălina, Nicolescu, Alexandru, Pop, Roxana, Bunea, Andrea, Rugina, Dumitrita, Pintea, Adela
• Format: Article
• Language: English
• Subjects: Acetylcholinesterase; Acids; Amelanchier; Amelanchier lamarckii; Anthocyanins; antioxidant; Antioxidants; Berries; bioaccessibility; Bioavailability; Diabetes mellitus; Diet; enzyme inhibition; Enzymes; Epithelial cells; Epithelium; Flavonols; Fruits; Functional foods & nutraceuticals; Galactosides; Glucose; Glucosidase; Hyperglycemia; juneberries; Kaempferol; Metabolic disorders; Phenolic acids; phenolics; Phenols; Pigmentation; Polyphenols; Reactive oxygen species; Skin; Tyrosinase; Vitamin E; α-Glucosidase
• ISSN: 2223-7747; 2223-7747
• DOI: 10.3390/plants13101347

The present study aimed to investigate the chemical content of Romanian juneberries ( ), their effect on antioxidant and enzyme inhibition activities, and their bioaccessibility after simulated in-vitro digestion. In extract (AME), 16 polyphenolic compounds were identified by LC-ESI+-MS analysis. The most representative compounds found in the extract were cyanidin-galactoside, 3,4-dihydroxy-5-methoxybenzoic acid, feruloylquinic acid, and kaempferol, all belonging to the anthocyanins, phenolic acids, and flavonols subclasses. The polyphenols of AME exert quenching abilities of harmful reactive oxygen species, as the CUPRAC antioxidant assay value was 323.99 µmol Trolox/g fruit (FW), whereas the FRAP antioxidant value was 4.10 μmol Fe /g fruit (FW). Enzyme inhibition assays targeting tyrosinase (IC50 = 8.843 mg/mL), α-glucosidase (IC50 = 14.03 mg/mL), and acetylcholinesterase (IC50 = 49.55 mg/mL) were used for a screening of AME's inhibitory potential against these key enzymes as a common approach for the discovery of potential antidiabetic, skin pigmentation, and neurodegenerative effects. The screening for the potential antidiabetic effects due to the α-glucosidase inhibition was performed in glucose-induced disease conditions in a human retinal pigmented epithelial cell experimental model, proving that AME could have protective potential. In conclusion, AME is a valuable source of phenolic compounds with promising antioxidant potential and metabolic disease-protective effects, warranting further investigation for its use in the nutraceutical and health industries.